Gorse, G J <br/><br/>
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.  [electronic resource] 

 -  The Journal of infectious diseases  Feb 1996 
 - 330-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1093/infdis/173.2.330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS Vaccines--administration & dosage<br/>Adult<br/>Amino Acid Sequence<br/>Dose-Response Relationship, Immunologic<br/>Double-Blind Method<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>HIV Antibodies--analysis<br/>HIV Envelope Protein gp120--chemistry<br/>HIV-1--immunology<br/>Humans<br/>Lymphocyte Activation<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Neutralization Tests<br/>Peptide Fragments--chemistry